HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Croda

This article was originally published in The Rose Sheet

Executive Summary

Marine biotech company Aquapharm Biodiscovery Ltd and ingredient supplier Croda International sign three-year deal giving Croda exclusive license to "novel marine-derived natural products identified through the collaboration from strains from Aquapharm's proprietary microbial library for use in topical cosmetic applications in skin and hair care," according to release. Croda will provide funding for Aquapharm to conduct research, along with royalties and milestone payments on commercialization of any resulting products. "The collaboration with Aquapharm is a key part of our strategy in developing novel, sustainable solutions for the personal-care industry," says Dr. Keith Layden, president of Croda...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS015606

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel